Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AZD-0901 by AstraZeneca for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
AZD-0901 is under clinical development by AstraZeneca and currently in Phase III for Adenocarcinoma Of The Gastroesophageal Junction. According to...
Data Insights
AZD-0901 by AstraZeneca for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
AZD-0901 is under clinical development by AstraZeneca and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...